Scientific programme
PROSCA on-demand
Registered delegates will receive an email with the link to the presentations.
PROSCA live broadcast
14 October 2020
19:00-22:00 (CEST)
Moderator: Bertrand Tombal
Watch the highlights of the presentations and learn more on PCa with case discussions and debates.
BLADDR on-demand
Watch expert presentations on bladder cancer from Saturday 10 October 2020 onwards.
Registered delegates will receive an email with the link to the presentations.
BLADDR live broadcast
15 October 2020
19:00-22:00 (CEST)
Moderator: Eva Comperat
Watch the highlights of the presentations and learn more on BCa with live case discussions and debates.
PROSCA 2020 On-demand presentations
From Saturday 10 October 2020 onwards
Session 1
Controversies in localised prostate cancer
Johan Stranne
Robotic surgery: new techniques for continence preservation
Ashutosh Tewari
Debate: Intermediate-risk prostate cancer: patients do care if QoL is fair
Panel: Alberto Bossi, Christian Gratzke, Alison Tree
Session 2
Advanced prostate cancer
Treatment advances in mHSPC
Ursula Vogl
The current landscape of nmCRPC
Charles Ryan
Immunotherapy for advanced prostate cancer: progress and new hopes
Petros Grivas
Session 3
What’s the role of novel imaging in daily clinical practice?
Jeremie Calais
Anwar Padhani
Session 4
Genetic testing in practice
Genetic testing for prostate cancer: are you ready?
Derya Tilki
PARP inhibitors: which patients will benefit?
Elena Castro
PROSCA 2020 Live broadcast
Wednesday 14 October 2020
19:00 – 22:00 (CEST)
Moderator: Bertrand Tombal
19:00
Welcome
Bertrand Tombal
19:10
Controversies in localised prostate cancer
Panel: Siska Van Bruwaene, Piet Dirix
Presenters: Johan Stranne, Ashutosh Tewari
Case discussion panel: Alberto Bossi, Christian Gratzke, Alison Tree
Key messages
- The role of MRI in active surveillance
- Robotic surgery
- Intermediate-risk prostate cancer: patients do care if QoL is fair
Voting & case discussion
Summary
19:45
Short break
19:50
Advanced prostate cancer
Panel: Daan De Maeseneer
Presenters: Ursula Vogl, Charles Ryan, Petros Grivas
Key messages
- Treatment advances in mHSPC
- The current landscape of nmCRPC
- Immunotherapy for advanced prostate cancer: progress and new hopes
Voting & case discussion
Summary
20:25
Best posters
20:30
Break
20:40
What’s the role of novel imaging in daily clinical practice?
Panel: Piet Ost, Nicolas Mottet
Presenters: Jeremie Calais, Anwar Padhani
Key messages
- PSMA-PET: does it make a difference for patients at high-risk for de novo N1 disease?
- How to deliver a high-quality diagnostic service: focus on MRI
Voting & case discussion
Summary
21:15
Short break
21:20
Genetic testing in practice
Panel: Piet Ost
Presenters: Derya Tilki, Elena Castro
Key messages
- Genetic testing for prostate cancer: are you ready?
- PARP inhibitors: which patients will benefit?
Voting & case discussion
Summary
21:55
Wrap up
BLADDR 2020 On-demand presentations
From Saturday 10 October 2020 onwards
Session 1
New options in NMIBC
Kilian M. Gust
BCG-refractory NMIBC: what now?
Ashish Kamat
Prognostic markers: role in follow-up of patients with NMIBC
Hugh Mostafid
Session 2
MIBC
Neoadjuvant and adjuvant therapy: what did we learn in 2020 and what can we expect in the near future?
Maria De Santis
Variant histologies: what’s new?
Eva Comperat
Frederiek D’Hondt
Peter Hoskin
Shaista Hafeez
Session 3
Advanced UCa
Arlene Siefker-Radtke
Metastatic UCa: a glimpse of the near future
Ignacio Durán
cN+ M0 BCa: curative or palliative treatment plan?
Marco Moschini
BLADDR 2020 Live broadcast
Thursday 15 October 2020
19:00 – 22:00 (CEST)
Moderator: Eva Comperat
19:00
Welcome
Eva Comperat, Piotr Chlosta
19:10
New options in NMIBC
Panel: Jacques Irani, Jeroen van Moorselaar
Presenters: Kilian M. Gust, Ashish Kamat, Hugh Mostafid
Key messages
- Intravesical alternatives to BCG
- BCG-refractory NMIBC: what now?
- Prognostic markers: role in follow-up of patients in NMIBC
Voting & case discussion
Summary
19:55
Break
20:05
MIBC
Panel: Frederiek D’Hondt, Valérie Fonteyne
Presenters: Maria De Santis, Eva Comperat, Frederiek D’Hondt, Peter Hoskin, Shaista Hafeez
Key messages
- Neoadjuvant and adjuvant therapy: what did we learn in 2020 and what can we expect in the near future?
- Variant histologies: what’s new?
- Robotic intracorporeal urinary diversion: does it pay off?
- Advances in RT: focus on hypofractionation
- RT + IO: a golden combination?
Voting & case discussion
Summary
20:50
Best posters
20:55
Break
21:05
Advanced UCa
Panel: Karel Decaestecker, Emmanuel Seront
Presenters: Arlene Siefker-Radtke, Ignacio Durán, Marco Moschini
Key messages
- Optimising treatment for advanced UCa: combination, maintenance or sequencing?
- Metastatic UCa: a glimpse of the near future
- cN+ M0 BCa: curative or palliative treatment plan?
Voting & case discussion
Summary
